user
menu
letter
Sign InRegister
langEnglisharrow

LY75

LY75

LY75 詳細

Molecule Name
Lymphocyte antigen 75
分子の別称
LY75,CD205,DEC-205,CLEC13B,Lymphocyte antigen 75,gp200-MR6
Drug Development Progress
治験薬の数1
市販薬剤の数0
研究＆開発段階Phase 1 Clinical
ターゲットの別称
LY75，CD205，Lymphocyte Antigen 75，C-Type Lectin Domain Family 13 Member B，CLEC13B，DEC-205，CD205 Antigen，Gp200-MR6，Ly-75
バックグランド
lymphocyte antigen 75 (Ly 75, also known as CD205, CLEC13B, GP200-MR6 and DEC-205, is a type I transmembrane protein that is primarily expressed on dendritic cells and thymic epithelial cells. LY75 functions as an endocytic receptor for antigens. MEN1309/OBT076, the first antibody drug targeting CD205, has shown strong preclinical anti-tumor activity in lymphoma. After being verified as a single drug in vivo, the antibody-drug conjugate has a synergistic effect with the BCL2 inhibitor Venetoclax and the anti-cd20 monoclonal antibody rituximab.

LY75 製品リスト

Species
  • Human（1）
  • Mouse（1）
Tag
  • His Tag（2）
Host
  • HEK293（2）
Conjugate
  • Unconjugated（2）
Grade
  • RUO（2）
Low Endotoxin
  • No（2）
MoleculeCat. No.Product Name種HostStructurePurityActivitySize&Price
LY75
LY5-H52H3
Human LY75 / CD205 Protein, His Tag
Human
HEK293
SDS-PAGE
ELISA

$360.00

100ug
LY75
LY5-M52H5
Mouse LY75 / CD205 Protein, His Tag (MALS verified)
Mouse
HEK293
MALSSDS-PAGE

$360.00

100ug
You Have Viewed 1-2 Of 2 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

お問い合わせRequest Customization
Asset Licensing Opportunity
Resources

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
Oberotatug ravtansineOBT-076; MEN1309/OBT076; MEN-1309Phase 1 ClinicalMenarini, Oxford Biotherapeutics Ltd
Carcinoma, Adenoid Cystic; Head and Neck Neoplasms; Lymphoma, Non-Hodgkin; Solid tumours
詳細
Customer Reviews